Inventor · disambiguated record
Sara Majocchi
Also filed as: MAJOCCHI SARA
1 granted patent·4 pending applications·0 citations·filing 2020–2024
2Inventor score
Top patents by PatentIndex Score
5 records- 0161US2025075000A1Combination therapy with a cea x cd28 bispecific antibody and blocking anti-pd-1 antibodies for enhanced in vivo anti-tumor activityNOVIMMUNE SA·Filed 2024·Application pending·0 cites
- 0260US2024254234A1PD-L1xCD28 BISPECIFIC ANTIBODIES FOR IMMUNE CHECKPOINT-DEPENDENT T CELL ACTIVATIONNOVIMMUNE SA·Filed 2023·Application pending·0 cites
- 0356US2024002544A1Cd28 bispecific antibodies for targeted t cell activationNOVIMMUNE SA·Filed 2023·Application pending·0 cites
- 0452US2024084001A1Bispecific antibodies against ceacam5 and cd47LAMKAP BIO BETA LTD·Filed 2022·Application pending·0 cites
- 0537US12441807B2Bispecific antibodies against CEACAM5 and CD3Lamkap Bio Alpha AG·Filed 2020·Granted Oct 14, 2025·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Sara Majocchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →